ISPE Releases Product Quality Lifecycle Implementation (PQLI®) Good Practice Guide

Print this page         

FOR IMMEDIATE RELEASE

Contact:
Danielle Hould
ISPE Communications Manager
Tel: +1-813-960-2105, ext. 277
Fax: +1 813.264.2816
dhould@ispe.org
www.ISPE.org

ISPE Releases Product Quality Lifecycle Implementation (PQLI®) Good Practice Guide

(TAMPA, FLORIDA, USA, 20 October 2010)ISPE, a global not-for-profit association of 22,000 pharmaceutical science and manufacturing professionals, has released a new Good Practice Guide (GPG), titled Product Quality Lifecycle Implementation (PQLI) Guide: Overview of Product Design, Development, and Realization: A Science- and Risk-Based Approach to Implementation. This Guide, which is the first in a series of ISPE PQLI Good Practice Guides, is being offered online as a free download for ISPE Members, and at a cost of $25 for non-Members.

The Guide is an introduction to and an overview of the PQLI Guides Series, which collectively address product and process development, transfer to, and establishment of, commercial manufacture using science- and risk-based approaches. The series uses ICH guidelines Q8 (R2), Pharmaceutical Development, Q9, Quality Risk Management, and Q10, Pharmaceutical Quality System as a basis, together with other relevant ICH guidelines. The PQLI initiative and Good Practice Guide series are the result of several years’ work by an international team of dedicated volunteers.

“ISPE’s Product Quality Lifecycle Implementation (PQLI) initiative provides the linkage between the high-level ICH guidelines and the needs of those wanting to implement them,” said PQLI Project Manager John Berridge. “This program is critically important in order to share the latest developments from those directly involved in ICH and contribute to clarifying the issues and opportunities of implementation.”

The subsequent Guides in the PQLI series are tentatively scheduled for release in summer 2011, and will cover topics such as critical quality attributes and critical process parameters, design space, control strategy, and an illustrative example using a small molecule case study.

The objective of this series of Guides is to provide a range of how to tools for practitioners developing products and their manufacturing processes using the enhanced, Quality by Design (QbD) approach described in ICH guideline, Q8 (R2). The Guides aim to give more insight than is given in the ICH Guidelines, and include more explanation and examples of individual topics. This series is intended to assist industry in the development and implementation of pragmatic and practical how to approaches to product realization using the QbD approach supported by sound scientific, engineering, and business principles.

About ISPE

ISPE, the International Society for Pharmaceutical Engineering, is the Society of choice for 24,000 technical professionals working in or serving the manufacturing sector or drug development in the pharmaceutical industry in 90 countries. ISPE aims to be the catalyst for "Engineering Pharmaceutical Innovation" by providing Members with opportunities to develop their technical knowledge, exchange practical experience within their community, enhance their professional skills, and collaborate with global regulatory agencies and industry leaders. Founded in 1980, ISPE offers online learning opportunities for a global audience and has its worldwide headquarters in Tampa, Florida, USA; its European office in Brussels, Belgium; an Asia Pacific office in Singapore; and its newest office in Shanghai, China. Visit www.ISPE.org for additional Society news and information.

Last Update: 29 May 2012

My ISPE

  • Click to go to My Communities of Practice
  • Click to go to My Affiliate or Chapter
  • Click to go to My Profile
Click to go to the Member Gift